BioSpace News Archive

Two-time national championship LFL Wide Receiver and current Quarterback of the Seattle Mist are now tackling sports injuries off the field by bringing AXIS Stem Cell Institute to the greater Seattle area.

In the wake of the recent Ridgecrest earthquakes and the state of emergency declared by California Governor Gavin Newsom, Molina Healthcare of California has immediately removed barriers to care for affected members.

Chicago-based medical device company BandGrip, transforming the wound-closure market with its Micro-Anchor Skin Closures, connects with Indianapolis-based orthopedic practice OrthoIndy to improve patient outcomes while saving surgical time.

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended June 30, 2019

NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a regenerative medicine company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, today announced that Ernest Wong, President and CEO, will present live at VirtualInvestorConferences.com on July 11th.

AblaCare, a medical device company dedicated to transforming women’s health and fertility care, announced today that it has raised €10 million in Series A financing from Sofinnova Partners.

Ferring Pharmaceuticals today welcomes the World Health Organization’s (WHO) addition of heat-stable carbetocin to the WHO Model List of Essential Medicines (EML) of uterotonics for the prevention of excessive bleeding after birth.

SparingVision, a biotechnology company specializing in the research and development of innovative therapies for treating hereditary retinal degenerative diseases such as retinitis pigmentosa, has today announced that it has been awarded non-dilutive funding of €2.5 million, having submitted a winning proposal for the European EIC Accelerator (SME instrument Phase 2) program.

Orexo AB (publ.) has resolved to prepay SEK 32.5 million, corresponding to 10 percent, of the unsecured corporate bond loan of in total SEK 325 million, which was issued by the company in November 2017 and which carries a floating interest rate of STIBOR 3m +4.50 percent.

The Pancreatic Cancer Action Network (PanCAN) announced today that its PurpleStride Washington, D.C. 2019 event has raised more than $1 million, a fundraising milestone for the organization’s national signature 5K event.